UBS Group AG - GLYCOMIMETICS INC ownership

GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 85 filers reported holding GLYCOMIMETICS INC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of GLYCOMIMETICS INC
ValueSharesWeighting
Q2 2023$11,002
-23.5%
6,323
-44.6%
0.00%
Q1 2023$14,389
+43.9%
11,420
-33.8%
0.00%
Q3 2022$10,00017,262
+53843.8%
0.00%
Q1 2022$0
-100.0%
32
-99.8%
0.00%
Q4 2021$30,00021,054
+65693.8%
0.00%
Q3 2021$0
-100.0%
32
-99.7%
0.00%
Q2 2021$24,000
-71.1%
10,302
-62.5%
0.00%
Q1 2021$83,000
-62.6%
27,454
-53.5%
0.00%
Q4 2020$222,000
+68.2%
58,998
+37.6%
0.00%
Q3 2020$132,000
-35.3%
42,881
-20.9%
0.00%
Q2 2020$204,000
+35.1%
54,244
-17.9%
0.00%
Q1 2020$151,000
-67.9%
66,059
-25.7%
0.00%
Q4 2019$471,000
+154.6%
88,955
+107.6%
0.00%
Q3 2019$185,000
-71.8%
42,839
-22.2%
0.00%
Q2 2019$656,000
-28.9%
55,052
-25.6%
0.00%
Q1 2019$922,000
+112.4%
73,973
+61.4%
0.00%
Q4 2018$434,000
+65.0%
45,840
+150.8%
0.00%
Q3 2018$263,000
+5160.0%
18,281
+5993.7%
0.00%
Q2 2018$5,000
-99.8%
300
-99.8%
0.00%
-100.0%
Q1 2018$2,035,000
+40600.0%
125,355
+41685.0%
0.00%
Q4 2017$5,000
-84.4%
300
-86.8%
0.00%
Q3 2017$32,000
+700.0%
2,281
+431.7%
0.00%
Q2 2017$4,000
-60.0%
429
-76.3%
0.00%
Q1 2017$10,000
-47.4%
1,809
-42.4%
0.00%
Q4 2016$19,000
+280.0%
3,142
+322.3%
0.00%
Q3 2016$5,000
-28.6%
744
-36.0%
0.00%
Q1 2016$7,000
-12.5%
1,162
-16.2%
0.00%
Q3 2015$8,000
-50.0%
1,386
-31.7%
0.00%
Q2 2015$16,000
+77.8%
2,028
+87.6%
0.00%
Q1 2015$9,0001,0810.00%
Other shareholders
GLYCOMIMETICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
BVF INC/IL 3,229,856$45,186,0005.74%
NEA Management Company, LLC 8,584,128$120,092,0004.21%
NEXTHERA CAPITAL LP 321,286$4,495,0001.16%
Redmile Group, LLC 1,214,088$16,985,0000.84%
EAM Investors, LLC 371,030$5,191,0000.69%
Schonfeld Strategic Advisors LLC 500,104$6,996,0000.64%
ELEMENT CAPITAL MANAGEMENT LLC 29,909$418,0000.17%
Jafra Capital Management LP 16,839$236,0000.09%
PRENTISS SMITH & CO INC 20,000$280,0000.08%
Endurant Capital Management LP 17,607$246,0000.08%
View complete list of GLYCOMIMETICS INC shareholders